Академический Документы
Профессиональный Документы
Культура Документы
DM + ULKUS PEDIS
Oleh:
dr. Dananjaya
Pembimbing:
dr. Agus Dahana, Sp.PD, FINASIM
dr. Fonyta Sugianto
dr. Wiji Kusbiyah
Pendahuluan
Ulkus adalah luka
terbuka pada
permukaan kulit atau
kematian jaringan
yang luas dan
disertai invasi bakteri
Merupakan salah
satu gejala klinik dan
perjalanan penyakit
Diabetes Melllitus
dengan neuropati
perifer
22/6/2015 Nyeri (+), Pus (+) TD: 120/80, N: 79x/mnt, DM + ulkus pedis D + - Rawat luka
RR: 21x/mnt, T: 37,5 leukositosis - Inf RL 20tpm drip
GDA: 115,9 neurosanbe 3x1 amp
Leukosit: 25.900 - Inj ceftriaxone 2x1 gr
Hb: 10,9 - Inj ranitidine 3x1
Trombosit: 330.000 - Metronidazole 3x1
- Inj santagesic
3x1amp
- Apidra 4-4-4
- Lantus 10-0-0
- Oral: clindamycin
2x300mg, sucralfat
3xC1
23/6/2015 Nyeri (+), pus(+) TD: 130/80, N: 82x/mnt, DM + ulkus pedis D + - Rawat luka
RR: 20x/mnt, T: 37,7 leukositosis - Inf RL 20tpm drip
GDA: 59,9 neurosanbe 3x1amp
Hb: 11,0 - Inj ceftriaxone
Trombosit: 313.000 2x1gr
Leukosit: 22.000 - Inj Ranitidine
3x1amp
- Inj Santagesic
3x1amp
- Metronidazole 3x1
- Lantus 10-0-0
- Apidra stop
- Pasang DC
24/6/2015 Nyeri (+), pus (+) TD: 110/70, N: 79x/mnt, DM + ulkus pedis D + - Rawat luka
RR: 21x/mnt, T: 37,6 leukositosis - Inf RL 20tpm drip
GDA: 117,5 neurosanbe 3x1
Hb: 11,3 - Inj Ceftriaxone
Trombosit: 311.000 2x1gr
Leukosit: 20.000 - Inj Ranitidin
3x1amp
- Inj Santagesic
3x1amp
- Metronidazole 3x1
- Lantus stop
- Oral: metformin
2x500mg, acarbose
2x1
25/6/2015 Nyeri (-), pus (+), Diare (+) TD: 120/70, N: 80x/mnt, DM + ulkus pedis D + - Rawat luka
3x, warna kuning, ampas. RR: 20x/mnt, T: 37,5 leukositosis - Inf RL 20tpm drip
GDA: 178,4 neurosanbe 3x1
Hb: 11,3 - Inj Ceftriaxone 2x1gr
Trombosit: 315.000 - Inj Ranitidin 3x1amp
Leukosit: 18.700 - Inj Santagesic
3x1amp stop
- Metronidazole 3x1
- Oral: attapulgit 3x1,
clindamycin
2x300mg, sucralfat
3XC1
26/6/2015 Nyeri (-), pus < TD: 130/90, N: 82x/mnt, DM + ulkus pedis D + - Rawat luka
RR: 21x/mnt, T: 37,7 leukositosis - Inf RL 20tpm drip
GDA: 105,6 neurosanbe 3x1
Hb: 12,0 - Inj Ceftriaxone 2x1gr
Trombosit: 310.000 - Inj Ranitidin 3x1amp
Leukosit: 15.900 - Metronidazole 3x1
27/6/2015 Keluhan (-) TD: 120/90, N: 80x/mnt, DM + ulkus pedis D + KRS
RR: 20x/mnt, T: 37,5 leukositosis Oral: acarbose 2x1,
GDA: 151,4 metformin 2x500mg,
Hb: 12,0 clindamycin 2x300mg,
Trombosit: 315.000 roborantia 1x1
Leukosit: 13.400 Kontrol poli 3 hari lagi
TINJAUAN PUSTAKA
DIABETES MELLITUS
What is diabetes?
Diabetes mellitus (DM) is a group of diseases characterized by high
levels of blood glucose resulting from defects in insulin production,
insulin action, or both.
Diabetic ketoacidosis
Hypoglycemia
Chronic complications
• Chronic complications-------------Vascular
Disease
Vascular Disease
MICROVASCULAR AND
MACROVASCULAR
DIABETIC NEUROPATHY
DIABETIC NEPHROPATHY
DIABETIC RETINOPATHY
DIABETIC CARDIOMIOPATHY
DIABETIC ANGIOPATHY
Microvascular and Macrovascular
• Growth of friable and poor-quality new blood vessels in the retina as well
as macular edema (swelling of the macula), which can lead to severe vision
loss or blindness. Retinal damage (from microangiopathy) makes it the most
common cause of blindness among non-elderly adults in the US.
Diabetic cardiomyopathy
Short-term use:
Acute illness, surgery, stress and emergencies
Pregnancy
Breast-feeding
Insulin may be used as initial therapy in type 2 diabetes
in marked hyperglycaemia
Severe metabolic decompensation (diabetic ketoacidosis,
hyperosmolar nonketotic coma, lactic acidosis, severe
hypertriglyceridaemia)
Long-term use:
If targets have not been reached after optimal dose of combination
therapy or BIDS, consider change to multi-dose insulin therapy.
When initiating this,insulin secretagogues should be stopped and
insulin sensitisers e.g. Metformin or TZDs, can be continued.
Self-Care